TLX News: Telix and Wiik Pharma Sign Distribution Agreement for Illuccix® in the Nordic Region - 8th Nov 2023, 4:00pm

[annb0t]

MELBOURNE, Australia, Nov. 8, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed an exclusive agreement with Denmark-based WIIK Pharma ApS (Wiik Pharma) for the distribution of Telix's investigational prostate cancer imaging agent, Illuccix® (TLX591-CDx, Kit for the preparation of 68Ga-PSMA-11 injection) in the Nordic region. (PRNewsfoto/Telix Pharmaceuticals Limited)

Under the terms of the agreement, Wiik Pharma, a specialist s...

>>> Read more: Telix and Wiik Pharma Sign Distribution Agreement for Illuccix® in the Nordic Region